Emerging Business Models in the Pharmaceutical Industries ...

Introduction
GlaxoSmithKline (GSK) and its
subsidiaries and associated undertakings
constitute a global health care group
engaged in the creation, discovery,
development, manufacture and
marketing of pharmaceuticals
(prescription pharmaceuticals and
vaccines), and consumer health care
products (over-the-counter medicines,
oral care and nutritional healthcare).
GSK has operations in 38 countries with
the principal research and development
facilities located in the United Kingdom,
the United States, Japan, Italy and
Belgium.
Products are sold in over 130 countries,
and the major markets are the United
States, Japan, France, Germany, the
United Kingdom and Italy.
GlaxoSmithKline plc
-
Revenues
The group is able to continue to deliver pharmaceutical turnover growth,
despite generic competition, primarily due to a broad product portfolio of fast
growing, high value products.
50
40
30
20
10
GSK Revenue by Segment
15% (in percentage)
85%
Pharmaceutical
Consumer
Healthcare
GSK's Five Year Financial Performance (in billion US$)
1999 2000 2001 2002 2003
Source: Company’s Annual Reports
Source: Company’s Annual Reports
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players 60
34%
32%
30%
28%
26%
24%
Revenues
Operating Profits
Profit Margins